EP 1228044 A2 20020807 - PYRROLO IMIDAZOLE DERIVATIVES AND THEIR USE AS MEDICAMENTS
Title (en)
PYRROLO IMIDAZOLE DERIVATIVES AND THEIR USE AS MEDICAMENTS
Title (de)
PYRROLOIMIDAZOL-DERIVATE UND IHRE VERWENDUNG ALS ARZNEIMITTEL
Title (fr)
DERIVES DE PYRROLO-IMIDAZOL ET LEUR UTILISATION COMME MEDICAMENTS
Publication
Application
Priority
- DE 19948417 A 19991007
- EP 0009904 W 20001009
Abstract (en)
[origin: DE19948417A1] The invention relates to 3-pyrrolo imidazole derivatives of general formula (I), wherein: the imidazole radical is an optionally substituted imidazole cycle; X, Y, A and B, independent of one another, represent carbon atoms or nitrogen atoms; radicals Z, independent of one another, represent a hydrogen atom, a halogen atom, a pseudohalogen, an optionally substituted alkyl radical, alkenyl radical, alkynyl radical, aralkyl radical, aralkenyl radical, aralkynyl radical, cycloalkyl radical, cycloalkenyl radical, cycloalkynyl radical, cycloaralkyl radical, cycloaralkenyl radical, cycloaralkynyl radical, aryl radical, alkoxy radical or an optionally substituted ring, on which one or two additional optionally substituted rings can be anellated, and/or at least two of the radicals Z can be part of an optionally substituted ring, on which one or two additional optionally substituted rings can be anellated. The invention also relates to pharmaceutical compositions which contain at least one of the aforementioned compounds, optionally in conjunction with conventional supports and/or adjuvants and/or auxiliary agents.
IPC 1-7
IPC 8 full level
A61K 9/127 (2006.01); A61K 31/4178 (2006.01); A61K 31/437 (2006.01); A61K 31/454 (2006.01); A61K 39/395 (2006.01); A61P 31/04 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 471/04 (2006.01)
CPC (source: EP US)
A61P 31/04 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/02 (2017.12 - EP); C07D 401/14 (2013.01 - EP US); C07D 403/04 (2013.01 - EP US); C07D 471/04 (2013.01 - EP US)
Citation (search report)
See references of WO 0125213A2
Citation (examination)
- Pharm.Chem.J.(Engl.Transl.), 2, 1970, 68
- Gazz.Chim.Ital., 87, 1957, 11,18
- J.Org.Chem. 65, 5, 2000, 1516 - 1524
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL
DOCDB simple family (publication)
DE 19948417 A1 20010419; AU 1853101 A 20010510; CA 2386795 A1 20010412; EP 1228044 A2 20020807; JP 2003511373 A 20030325; US 6699883 B1 20040302; WO 0125213 A2 20010412; WO 0125213 A3 20010607; WO 0125213 B1 20011018
DOCDB simple family (application)
DE 19948417 A 19991007; AU 1853101 A 20001009; CA 2386795 A 20001009; EP 0009904 W 20001009; EP 00981195 A 20001009; JP 2001528159 A 20001009; US 8991702 A 20020404